Rhythm Pharmaceuticals, Inc. (RYTM)
$89.64+1.35%Close
SELLBEAR · day 14
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $6.1B
- Beta
- 1.97
- P/E (TTM)
- -29.19
- Short % float
- 18.48%
- Days to cover
- 20.1
- SI change
- -0.1%
- 1W
- -4.04%
- 1M
- -11.30%
- vs SPY 1W
- -5.59%
- vs SPY 1M
- -13.06%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDSELLRevolution Medicines, Inc.$43.9BRECOVERYQ 30$206.64-6.35%
- NUVLBUYNuvalent, Inc.$9.1BBULLQ 42$123.96+0.00%
- PTGXSELLProtagonist Therapeutics, Inc.$9.0BBEARQ 32$140.06-0.72%
- ACLXArcellx, Inc.$6.7B$115.07
- KNSABUYKiniksa Pharmaceuticals International, plc$5.8BBULLQ 23$75.79+1.01%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- RLAYSELLRelay Therapeutics, Inc.$4.2BRECOVERYQ 2$18.96-3.01%
- VRDNSELLViridian Therapeutics, Inc.$2.2BCRISISQ -3$19.40+0.33%
- STOKSELLStoke Therapeutics, Inc.$1.7BCRISISQ 10$25.62-1.40%
- QURESELLuniQure N.V.$1.6BCRISISQ 17$23.46-2.59%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.6BCRISISQ 17$17.60-0.76%
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
